Innovation

Australian innovation pilot aims to reduce cost of vaccination in developing world

GSK has invested $7.7 million in a new pilot vaccine facility with the hope Australian manufacturing innovation could reduce cost of vaccination in developing world.

Innovation

A comic book on vaccines

Immunisation rates among Australian children has risen significantly over the years. However, there remains a distinct disparity between children from Aboriginal and Torres Strait Islander communities and other Australians.